Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.

Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial. Catheter Cardiovasc Interv. 2017 Nov 15; 90(6):1027-1037.

View in: PubMed

subject areas

Aged, 80 and over
Aged, 80 and over
Aortic Valve Stenosis
Aortic Valve Stenosis
Atrial Fibrillation
Atrial Fibrillation
Cause of Death
Cause of Death
Comorbidity
Comorbidity
Europe
Europe
Female
Female
Follow-Up Studies
Follow-Up Studies
Humans
Humans
Male
Male
Postoperative Complications
Postoperative Complications
Retrospective Studies
Retrospective Studies
Risk Factors
Risk Factors
Survival Rate
Survival Rate
Time Factors
Time Factors
Transcatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement
United States
United States

authors with profiles

Usman Baber